Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain.
Martínez-Lago N, Fernández-Montes A, Covela M, Brozos EM, De la Cámara J, Méndez Méndez JC, Jorge-Fernández M, Cousillas Castiñeiras A, Reboredo C, Arias Ron D, Pellón Augusto ML, González Villarroel P, Graña B, Salgado Fernández M, Carral Maseda A, Vázquez Rivera F, Candamio Folgar S, Reboredo López M; Galician Research Group on Digestive Tumors (GITuD).
Martínez-Lago N, et al.
BMC Cancer. 2021 Jan 14;21(1):64. doi: 10.1186/s12885-020-07758-5.
BMC Cancer. 2021.
PMID: 33446148
Free PMC article.